In the News

November 14th, 2019

Shear Insights: HemoShear Therapeutics Engages with European Metabolic Disease Consortium

Read More »
September 20th, 2019

Prestigious Journal Publishes HemoShear Research on Gene Expression and Liver Disease

Read More »
August 23rd, 2019

Takeda And HemoShear Therapeutics: The NASH Collaboration

Read more at Seeking Alpha
April 17th, 2019

Q&A on HemoShear’s 3D model of the tumor microenvironment

Read more at DDN News
November 9th, 2018

Shear Insights: HemoShear Identifies Novel Targets for Treating Liver Diseases

Read More »
September 6th, 2018

Shear Insights: HemoShear Invited to Share Expertise at 3D Modeling Conference

Read More »
July 19th, 2018

Shear Insights: HemoShear Therapeutics Continues to Engage with Rare Disease Groups

Read More »
May 24th, 2018

HemoShear technology utilized to create 3D model of cancer tumors

View on Cavalier Daily
May 7th, 2018

Pioneering New 3D Cancer Model to Speed New Treatments

View on UVA Health Newsroom
May 4th, 2018

Q&A with Brian Wamhoff, PhD, Head of Innovation, HemoShear Therapeutics

View on Rare Disease Report
April 20th, 2018

UVA biomedical engineering student gains real work experience at HemoShear

View on UVA Today
March 8th, 2018

HemoShear’s Maple Syrup Urine Disease Model Presented at Society for Inherited Metabolic Disorders Meeting

View on Rare Disease Report
View More +


HemoShear Therapeutics, Inc.
501 Locust Avenue
Suite 301
Charlottesville, Virginia 22902